Basel

Scientific Programme

The Academy day will have a range of educational symposia covering many different topics and will include interactive sessions. The main scientific programme will once again include new topics and new to ISBT speakers.

The plenary sessions will include ‘bridging the gap’ - looking at the impact of migration on transfusion medicine in Europe, ‘Big Data’ - the pros and cons of big data and big data in transfusion medicine and beyond, and the final plenary session on looking into the future with presentations on killer germs, gene therapy and ‘the Watt Worms’. The parallel sessions will be in the format regular attendees of ISBT congresses are familiar with, of one invited speaker with the remaining slots filled by orals from high scoring abstracts. The parallel sessions will cover the whole transfusion supply chain as well as sessions on challenges in resource limited settings.

The programme will include transfusion practitioner sessions, a young professional session and workshops. The scientific programme with invited speakers and topics will be available online the beginning of November. 

Programme per day

09.00-10.30Various facets of donor management
09.00-09.30Impact of blood donation on exercise tolerance
J. Helge, Denmark
09.30-10.00How does deferral impact the blood donor?
T. Davidson, Australia
10.00-10.30The gift of life - does it apply to donation for research?
V. Raivola, Finland
09.00-10.30Transfusion challenges in patients with sickle cell disease
09.00-09.30Immunohaematological features of patients with sickle cell disease
V. Thornier, France
09.30-10.00Phenotype and allele matching: how far should we go?
C. Folman, the Netherlands
10.00-10.30Management of delayed hemolytic transfusion reactions and hyperhemolysis syndrome
S. Trompeter, United Kingdom
10.30-11.00Coffee break
11.00-12.30Artificial Intelligence and Ethics
11.00-11.45The use of artificial intelligence to improve health care; what's in it for transfusion medicine?
B. Geerts, the Netherlands
11.45-12.30Incentives and Inducements - where to draw the line?
P. Flanagan, New Zealand
11.00-12.30Issues around transfusion in infants and children
11.00-11.30Platelet transfusion triggers in neonates
E. Lopriore, the Netherlands
11.30-12.00Diagnosing TACO in infants and children
F. Gauvin, Canada
12.00-12.30Applying PBM princples in paediatric patients
G. Crighton, Australia
12.30-13.30Lunch and Satellite Symposia
13.30-15.00Management of transfusion-transmitted infections
13.30-14.00Risk based decision making framework for blood safety: what's the case for ZIKA?
E. Bloch, USA
14.00-14.30Screening strategies to minimize the risk of TT-HEV infections
T. Vollmer, Germany
14.30-15.00Update on pathogen inactivation technology
M. Lozano, Spain
13.30-15.00Immunohaematology
13.30-14.00PP1PK: blood group system with an identity crisis
A. Hellberg, Sweden
14.00-14.30Why are the GATA and KLF regulator genes included in the Blood Group tables?
N. Nogues, Spain
14.30-15.00Cell free fetal DNA for fetal blood group genotyping: non-invasive prenatal testing
F. Clausen, Denmark
15.00-15.30Coffee break
15.30-17.00Novel technologies for transfusion medicine
15.30-16.00IT in blood banks, present and future. A Nordic perspective
H. G. Jensen, Denmark
16.00-16.30Applying drones for blood supply to remote areas. Rwanda experience
S. Gatare, Rwanda
16.30-17.00Novel challenges in blood inventory management and bedside transfusion
L. Lodge, United Kingdom
15.30-17.00Platelet and Granulocyte immunology
15.30-16.00Work-up in case of granulocyte antibodies
B. Flesch, Germany
16.00-16.30Optimal algorithms for serological and molecular typing in platelet alloantibodies
M. T. Ahlen, Norway
16.30-17.00Molecular basis of granulocyte antigens: what about HNA-2a
B. Bayat, Germany
Opening Ceremony and Welcome Reception
07.00-08.15Young Professionals Breakfast Session
08.30-10.00Donors and Donation
08.30.10.00Reach and retain donors in resource poor settings
L.Indermühle (CH)
08.30-10.00Adverse Events
08.30-09.00Metagenomics and blood-derived products
O. Preynat-Seauve (CH)
09.00-10.00Selected abstracts
08.30-10.00Clinical
08.30-09.00Long term erythrocyte exchanges in SCD: when should we stop
K. Yazdanbakhsh (USA)
09.00-10.00Selected abstracts
08.30-10.00Management and Organisation
08.30-09.00Management of transfusion in a long distance country
M. Syrjala (Finland)
09.00-10.00Selected abstracts
08.30-10.00Immunobiology of Blood Cells
08.30-09.00Pheno and Genotype in blood group typing - two sides of the coin
C. Westhoff (USA)
09.00-09.30TBA
C. Gassner (Switzerland)
09.30-10.00TBA
10.00-10.30Coffee break


 

 

10.30-12.00Plenary Session I: Bridging the gap
10.30-11.00Transfusion Strategies Trial in African Children: who needs blood and how much to give?
K. Maitland (UK)
11.00-11.30Global perspective of ethics in health supply - critical appraisal
S. Hurst Majno (Switzerland)
11.30-12.00Transfusion in limited infrastructure locations
A. Greinacher (Germany)
12.00-14.00Lunch break and Satellite Symposia
14.00-15.30Donors and Donation
14.00-14.30Donor motivation
H. Klüter (DE)
14.30-15.30Selected abstracts
14.00-15.30Adverse Events
14.00-14.30TTI and patients with immune deficiency: selected blood products or close monitoring
H. Hirsch (CH)
14.30-15.30Selected abstracts
14.00-15.30Clinical
14.00-14.30ITP treatment in paediatric patients
S. Holzhauer (DE)
14.30-15.30Selected abstracts
14.00-15.30Young Investigators Session
14.00-15.30Selected abstracts
14.00-15.30Immunobiology of Blood Cells
14.00-14.30Innate immunity and immune haemolytic anaemia
S.S. Zeerleder (Switzerland, the Netherlands)
14.30-15.30Selected abstracts
15.30-16.00Coffee break
16.00-17.30Donors and Donations
16.00-16.30Blood donation and iron loss, what are the implications?
M. Van Kraaij (NL)
16.30-17.30Selected abstracts
16.00-17.30Adverse Events
16.00-16.30Ending AIDS in Africa - vision or illusion?
N. Labhardt (CH))
16.30-17.30Selected abstracts
16.00-17.30Clinical
16.00-16.30A review of the therapeutics of thalassaemia
Y. Aydinok (Turkey)
16.30-17.30Selected abstracts
16.00-17.30Management and Organisation
16.00-16.30Benefits of thawed plasma in blood supply management
J. Zwaginga (NL)
16.30-17.30Selected abstracts
16.00-17.30Immunobiology of blood cells
16.00-16.30HLA- and Bloodgroup-Typing with NGS - One-stop shop
A. Franke (Germany)
16.30-17.30Selected abstracts
17.30-18.30Poster Session

07:00-08:15

Tranfusion Practitioner Networking Breakfast

08.30-10.00

Donors and Donation

08.30-09.00

Current issues in donor health
C. Erikstrup (Denmark)

09.00-10.00

Selected abstracts

08.30-10.00

Adverse Events

08.30-09.00

Approaches to control infections in various settings
M. Nübling (Germany)

09.00-10.00

Selected abstracts

08.30-10.00

Clinical

08.30-09.00

An update on Patient Blood Management
K. Pavenski (Canada)

09.00-10.00

Selected abstracts

08.30-10.00

Cellular Therapies

08.30-09.00

Tumour specific cellular therapies 
C. Arber (CH)

09.00-10.00

Selected abstracts

08.30-10.00

Immunobiology of blood cells

08.30-09.00

Detection of platelet auto antibodies to identify ITP state of the art
M. de Haas (the Netherlands)

09.00-10.00

Selected abstracts

10.00-10.30

Coffee break

10.30-12.00Plenary Session II: Big Data
10.30-11.00The 100,000 Genome project: How big data help patients with rare diseases (.... and rare blood groups)
W. Ouwehand (UK)
11.00-11.30Molecular Genetics to Genomics 
F. Yamamoto (Spain)
11.30-12.00Statistical Caution in Big Data Approaches to Transfusion Medicine Research
N. Roubinian (USA)
12.00-14.00Lunch break and Satellite Symposia
14.00-15.30Donors and Donation
14.00-14.30Keeping the blood flowing
L. Eberhart (Austria)
14.30-15.30Selected abstracts
14.00-15.30Adverse Events
14.00-14.30Update on TRALI/TACO and TAD (AABB pre meeting)
A. Vlaar (the Netherlands)
14.30-15.30Selected abstracts
14.00-15.30Clinical
14.00-14.30An update on Anti platelet agents
D. Cox (Ireland)
14.30-15.30Selected abstracts
14.00-15.30Challenges in resource-limited settings
14.00-14.30Challenges of blood processing in Africa
J. Mulenga (Zambia)  
14.30-15.00Challenges of clinical trials in resource limited settings
A. Kambugu (Uganda)
15.00-15.30PI in resource limited countries
S. Amar (Switzerland)
14.00-15.30Immunobiology of blood cells
14.00-14.30Understanding erythrocyte clearance
P. Buffet (France)
14.30-15.30Selected abstracts
15.30-16.00Coffee break
16.00-17.30Donors and Donations
16.00-16.30Change to voluntary nonremunerated donations in the Baltic states
R. Kullaste (Estonia)
16.30-17.30Selected abstracts
16.00-17.30Adverse Events
16.00-17.30Iron overload from transfusion and impact on allotransplant outcomes
U. Platzbecker (Germany)
16.00-17.30Clinical
16.00-16.30Platelet function measurements in transfusion medicine
P. Fontana (Switzerland)
16.30-17.30Selected abstracts
16.00-17.30Cellular Therapies
16.00-16.30Cellular therapies in the age of CRISPR-Cas
T. Cathomen (Germany)
16.30-17.30Selected abstracts
16.00-17.30Immunobiology of Blood Cells
16.00-16.30HLA in blood transfusion
Z. Grubic (Croatia)
16.30-17.30Selected abstracts
19.30-23.00Congress party
08.30-10.00Donors and Donation
08.30-09.00Impact of blood donor gender on recipient outcomes
R.A. Middelburg (the Netherlands)
09.00-10.00Selected abstracts
08.30-10.00Adverse Events
08.30-09.00Impact of pathogen inactivation on platelet survival and alloimmunization
A. Buser (Switzerland)
09.00-10.00Selected abstracts
08.30-10.00Clinical
08.30-09.00The importance and the approach to set up a system of hemovigilance
T. Aung (Myanmar)
09.00-10.00Selected abstracts
08.30-10.00Cellular Therapies, Management and Organisation
08.30-09.00T cell cellular therapies
M. Wolkers (NL)
09.00-10.00Selected abstracts
08.30-10.00Immunobiology of Blood Cells
08.30-09.00Factors influencing red blood cell alloimmunisation
J. Hendrikson (USA)
09.00-10.00Selected abstracts
10.00-10.30Coffee break

 

 

 

10.30-12.00Plenary session III: A Glimpse of the Future
10.30-11.00Invisible organs
R. Blasczyk (DE)
11.00-11.30Gene therapy in SCD
D. Bauer (US)
11.30-12.00The Watt Worms - take a deep breath
F. Zal (France)

Closing Ceremony

Farewell Lunch
14.00 - 15.30Anaemia management - The importance of the Transfusion Practitioner in the multidisciplinary team
Chairpersons C. So-Osman and TBA
14.00 - 14.20The importance of anaemia management and impact in the health care setting
A. Mo
14.20 - 15.00Anaemia assessment & management: the TP's role - processes, tips and resources for creating change
R. Moss & L. Bielby
15.00 - 15.30Panel Discussion
L. Bielby, R. Moss, C. So-Osman, A. Mo
07.00 - 08.15Transfusion Practitioner Networking Breakfast
Facilitated by Transfusion Practitioner Steering Committee members
14.00 - 15.30Transfusion Practitioner free communications: abstract presentations
Chairpersons L. Bielby and R. Moss